HPQ
53
3
HCP
54
7
PFG
36
3
CMA
53
3
EQIX
60
3
UNP
48
6
INTC
44
5
MKC
56
3
PCAR
56
7
GLW
48
2
GT
60
13
TROW
54
6
PEP
47
2
HRL
30
3
FOXA
63
3
WMB
63
3
COST
54
4
KMX
55
9
TGNA
37
-3
PSA
56
5
HPQ
53
3
HCP
54
7
PFG
36
3
CMA
53
3
EQIX
60
3
UNP
48
6
INTC
44
5
MKC
56
3
PCAR
56
7
GLW
48
2
GT
60
13
TROW
54
6
PEP
47
2
HRL
30
3
FOXA
63
3
WMB
63
3
COST
54
4
KMX
55
9
TGNA
37
-3
PSA
56
5
Financhill
Back

Adverum Biotechnologies Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

ADVM
Adverum Biotechnologies

Last Price:
7.91
Seasonality Move:
11.29%
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
28.89
Seasonality Move:
22.1%
Sell
50
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $7.72. The Score for ADVM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $28.08. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $7.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADVM is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $28.08
    The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 51.43 Buy
Chaikin Money Flow: 83651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.25 - 8.11) Buy
Bollinger Bands (100): (6.75 - 7.93) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 45.96 Sell
Chaikin Money Flow: 8609149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.04 - 28.04) Buy
Bollinger Bands (100): (30.03 - 39.99) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.69 Buy
20-day SMA: 7.82 Sell
50-day SMA: 7.35 Buy
200-day SMA: 10.29 Sell
8-day EMA: 7.68 Buy
20-day EMA: 7.68 Buy
50-day EMA: 7.54 Buy
200-day EMA: 9.02 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.62 Buy
20-day SMA: 27.47 Buy
50-day SMA: 31.83 Sell
200-day SMA: 44.76 Sell
8-day EMA: 27.81 Buy
20-day EMA: 28.14 Sell
50-day EMA: 30.87 Sell
200-day EMA: 40.98 Sell

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.75 per share, and an increase next year of $0.20 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and an increase next year of $1.33 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):